Trial Profile
Analgesic Efficacy and Safety of Etoricoxib in Ear Nose Throat Surgery.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 May 2022
Price :
$35
*
At a glance
- Drugs Etoricoxib (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- 28 Apr 2012 Additional lead trial centre added as reported by European Clinical Trials Database record.
- 28 Apr 2012 Actual end date (Jan 2010) added as reported by European Clinical Trials Database record.
- 28 Apr 2012 New source identified and integrated (European Clinical Trials Database record EudraCT2007-004274-10).